Bizarre Patents
A beach chair which can be adapted for a woman who is pregnant and wishes to sunbathe in the prone position.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8420809 | Process for the manufacturing of betamimetics The present invention relates to a process for preparing betamimetics of formula 1, wherein n denotes 1 or 2; R1 denotes hydrogen, halogen, C1-4 | 04/16/2013 |
| 8404837 | Quinoline derivatives as P13 kinase inhibitors Invented is a method of inhibiting the activity/function of PI3 kinases using quinoline derivatives. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerati... | 03/26/2013 |
| 8299242 | Synthesis of 2,4-pyrimidinediamines Disclosed herein are methods for synthesizing 2,4-pyrimidinediamines as well as intermediates used therein. ... | 10/30/2012 |
| 8252924 | Process for preparing benzomorpholine derivatives by hydrogenating o-nitrophenoxy carbonyl compounds A process for preparing benzomorpholine derivatives is described, in which an o-nitrophenoxy carbonyl compound is hydrogenated in the presence of extraneous metal-doped sponge metal catalysts based on nickel or cobalt with ring formation. ... | 08/28/2012 |
| 8222408 | Process for preparing acyl amide compounds A process for preparing acyl amide compounds is described, in which a recrystallized o-nitrophenoxy carbonyl compound is hydrogenated with hydrogen gas in the presence of a nickel sponge metal catalyst with ring closure to form a benzoxazine, which is then reacted w... | 07/17/2012 |
| 8163902 | Prodrugs of 2,4-pyrimidinediamine compounds and their uses The present disclosure provides prodrugs of biologically active 2,4-pyrimidinediamine compounds, salts and hydrates of the prodrugs, compositions comprising the prodrugs, intermediates and methods for synthesizing the prodrugs and methods of using the prodrugs in a ... | 04/24/2012 |
| 8138335 | Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient A compound represented by formula (I) wherein the symbols in the formula are the same meanings as those in specification, salts thereof, solvates thereof, or prodrugs thereof binds to DP receptor an... | 03/20/2012 |
| 8106190 | 2-aminobenzamide derivatives To provide a novel and excellent agent for treating or preventing nociceptive pain, neuropathic pain, cancer pain, headache, bladder function disorder and the like, based on the inhibitory action on the capsaicin receptor VR1 activation. The present invention... | 01/31/2012 |
| 7939658 | Enantiomeric pure beta agonists, manufacturing and use as a medicaments thereof The present invention relates to enantiomerically pure compounds of formula 1 wherein the groups m, n, B, X, R1, m and Ym− may have the meanings given in the claims and specification, methods for pre... | 05/10/2011 |
| 7928225 | Oxabispidine compounds for the treatment of cardiac arrhythmias There is provided compounds of formula I, wherein R1, R2, R3, R41 to R46, X, Y and Z have meanings given in the description, which compounds are useful in the prophylaxis and in the treatment of arrhythmias, in ... | 04/19/2011 |
| 7910730 | Process for the preparation of delmopinol and derivatives thereof A process for the preparation of delmopinol (3-(4-propylheptyl)-4-morpholinethanol) or a derivative or a pharmaceutically acceptable salt, or a solvate thereof, including a hydrate, comprises reacting oxazolidin [2,3-c] morpholine and a Grignard reagent, and optiona... | 03/22/2011 |
| 7902356 | Thiazolopyridinone derivates as MCH receptor antagonists The present invention relates to a melanin concentrating hormone antagonist compound of formula (I); wherein w, R1, q, p, R2, t, Ar1, L1, R3 and R4 are as defined, or a pharmaceutically acceptable sal... | 03/08/2011 |
| 7875715 | Compounds for the treatment of multi-drug resistant bacterial infections The present invention relates to compounds that demonstrate antibacterial activity, processes for their preparation, pharmaceutical compositions containing them as the active ingredient, to their use as medicaments and to their use in the manufacture of medicaments ... | 01/25/2011 |
| 7745621 | Long acting bronchodilators for the treatment of respiratory diseases The invention relates to compounds of general formula 1 wherein n, A, B, D, L, R1, R2, R3 and R4 may have the meanings given in the claims and in the specification, processes for ... | 06/29/2010 |
| 7589196 | Amine-substituted biphenyldiphosphines 1,1′-Biphenyl-2,2′-diphosphines having at least one amine substituent in the para position relative to the phosphine group and having the formulae are ligands for metal complexes which serve as catalysts for asymmetric ... | 09/15/2009 |
| 7563892 | Prodrugs of 2,4 pyrimidinediamine compounds and their uses The present disclosure provides the 2,4-pyrimidinediamine compound shown below, compositions comprising the compound, intermediates and methods for synthesizing the compound, and methods of using the compound in a variety of applications including treatment of autoi... | 07/21/2009 |
| 7563891 | Long wavelength thiol-reactive fluorophores Reactive fluorescent dyes compositions and methods of using same are disclosed. Squaraine nucleus, Nile Red nucleus, benzodioxazole nucleus, coumarin nucleus or aza coumarin nucleus dyes are disclosed having thiol-reactive groups. Squaraine nucleus, Nile Red nucleus... | 07/21/2009 |
| 7557207 | Spiro 2,4-pyrimidinediamine compounds and their uses The present invention provides methods of treating or preventing autoimmune diseases with spiro 2,4-pyrimidinediamine compounds, as well as methods of treating, preventing or ameliorating symptoms associated with such diseases. Specific examples of autoimmune diseas... | 07/07/2009 |
| 7491819 | N-[4-Fluorophenyl)methyl]-4,6,7,9-tetrahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-c][1,4]oxazine-2-carboxamide as an HIV integrase inhibitor The invention encompasses a series of bicyclic pyrimidinone compounds of Formula I which inhibit HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses ph... | 02/17/2009 |
| 7435814 | 2,4-Pyrimidinediamine compounds and their uses The present invention provides 2,4-pyrimidinediamine compounds that inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators, intermediates and methods of synthesizing the compounds and methods of using the compounds in a... | 10/14/2008 |
| 7435823 | Compounds and methods of use Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophyl... | 10/14/2008 |
| 7429583 | Betamimetics for the treatment of respiratory complaints The present invention relates to compounds of formula 1 wherein the groups n, m, B, X and R1 may have the meanings given in the claims and specification, processes for preparing them and their use as pharmaceutic... | 09/30/2008 |
| 7427616 | Condensed pyridines and pyrimidines with tie2 (TEK) activity A compound of the Formula (I), wherein A together with the carbon atoms to which it is attached forms a fused 5-membered heteroaryl ring, wherein said heteroaryl ring contains 1 or 2 heteroatoms selected from O, N and S, and wherein the 5-membered ring containing G ... | 09/23/2008 |
| 7427617 | Morpoline-bridged indazole derivatives The present invention relates to novel morpholine-bridged indazole derivatives having the formula which stimulate soluble guanylate cyclase, to a process for the preparation thereof, and to pharmace... | 09/23/2008 |
| 7423035 | Substituted cycloalkyl derivatives, process for the manufacture thereof and use thereof as medicament The present invention relates to compounds of formula 1 wherein the groups R1, R2, R3, R4, R5, R6, R7, R8, n, m and X may have the mean... | 09/09/2008 |
| 7423036 | Long-acting betamimetics for the treatment of respiratory complaints The present invention relates to compounds of formula 1, wherein n, A, R1, R2 and R3 may have the meanings specified in the description and claims, processes for preparing them and their use... | 09/09/2008 |
| 7420043 | Reagents for detecting efavirenz The invention provides derivatives of efavirenz and methods of making derivatives of efavirenz. The derivatives include immunogenic compounds for producing antibodies to efavirenz and labeled efavirenz tracers. These compounds are useful in immunoassay methods for d... | 09/02/2008 |
| 7417041 | Imidazopyrimidines as transforming growth factor (TGF) inhibitors Novel fused heteroaromatic compounds, including derivatives thereof, to intermediates for their preparation, to pharmaceutical compositions containing them and to their medicinal use are described. The compounds of the present invention are potent inhibitors of tran... | 08/26/2008 |
| 7414052 | Phenylaminopropanol derivatives and methods of their use The present invention is directed to phenylaminopropanol derivatives of formula I: or a pharmaceutically acceptable salt thereof, compositions containing these derivatives, and methods of their use for the prevention and tr... | 08/19/2008 |
| 7402598 | Arylethanolamine β-adrenoreceptor agonist compounds The present invention relates to compounds of formula (I) as defined herein and salts or solvates thereof. Processes for preparing these compounds and pharmaceutical formulations containing them are also disclosed, as well as methods for the prophylaxis of treatment... | 07/22/2008 |
| 7393845 | Heteroaryl derivates, their preparation and use A heteroaryl derivative having the formula (I). The compounds of the invention are considered useful for the treatment of affective disorders such as general anxiety disorder, panic disorder, obsessive compulsive disorder, depression, social phobia and eating disord... | 07/01/2008 |
| 7384937 | Fused heterocyclic compounds and use thereof Fused heterocylic compounds of the following Formula wherein R1, R2, R5, Z, J1 and J2 are described herein, and analogs thereof are provided which are useful in treatin... | 06/10/2008 |
| 7378415 | Benzoxazine and quinoxaline derivatives and uses thereof Compounds of the formula I: or a pharmaceutically acceptable salt, solvate or prodrug thereof, wherein k, m, n, p, q, X, Y, Z, Ar, R1, R2, R3 and R4 are as defined herein. Also pr... | 05/27/2008 |
| 7375104 | Long acting beta-2-agonists and their use as medicaments A compound of formula 1′ wherein: V is —CH2—, —NH—, or —O—; Ra and Rb are each independently hydrogen, C1-4-alkyl, or halogen-C1-4 | 05/20/2008 |
| 7371854 | Method for the production of bicyclic aromatic amino acids and intermediate products thereof Process for the preparation of integrin inhibitors of the formula (I), in which R1, R2, R3, R4, R5 and X have the meanings indicated in Claim 1, and intermediate compounds ... | 05/13/2008 |
| 7368445 | Fused pyrazole derivatives as TGF-β signal transduction inhibitors for the treatment of fibrosis and neoplasms The disclosed invention is directed to compounds of the formula: Formula (I) and methods of using these compounds. ... | 05/06/2008 |
| 7368567 | Arylsulfonyl benzodioxanes, benzoxazines and benzothiazines as 5-HT6 antagonists Compounds of the formula I: or pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein m, n, p, Ar, X, R1, R2, R3, R4, R5 and R6 are as defi... | 05/06/2008 |
| 7365065 | Non-peptide GnRH antagonists Compounds according to general formula 1, wherein A1-A3 are selected from A5 and A6 where A5 is either ═CR13— or ═N— and A6 is —NR14—, —O— or —S—; A4 | 04/29/2008 |
| 7365064 | Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them The present invention relates to novel antidiabetic, hypolipidemic, antiobesity and hypocholesterolemic compounds of formula (I) their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts,... | 04/29/2008 |
| 7354917 | Oxabispidine compounds and their use in the treatment of cardiac arrhythmias There is provided compounds of formula I, wherein R1, R2, R4, R41 to R46, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular... | 04/08/2008 |
